ArticleBlood advances2020

Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens.

Curtis A Lachowiez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.